Early data shows that the immune response to the third dose booster for the COVID-19 vaccine was 5- to 10-fold higher than after the second dose, said Pfizer CSO Mikael Dolsten. He also said that the antibody levels from the vaccine wane over time, raising risk of infection 6 months after vaccination.
Data shows immune response to third vaccine dose is stronger
